Efficacy and safety of intrapleural perfusion with hyperthermic chemotherapy for malignant pleural effusion: a meta-analysis.
Pan X, Hou Z, Zhang T, Ding Z, Ye F, Wang Z, Huang C, Wang P, Li X.
J Cardiothorac Surg. 2024 May 6;19(1):278. doi: 10.1186/s13019-024-02751-6.
PMID:38711077
Intrapleural perfusion hyperthermo-chemotherapy for malignant pleural dissemination and effusion.
Matsuzaki Y, Shibata K, Yoshioka M, Inoue M, Sekiya R, Onitsuka T, Iwamoto I, Koga Y.
Ann Thorac Surg. 1995 Jan;59(1):127-31. doi: 10.1016/0003-4975(94)00614-D.
PMID:7818311
Addition of bevacizumab to thoracic perfusion for treating malignant pleural effusions.
Weng C, Yu D, Meng Z, Pan F.
Asian J Surg. 2024 May;47(5):2331-2332. doi: 10.1016/j.asjsur.2024.01.176. Epub 2024 Feb 8.
PMID:38331611
Intracavitary perfusion with bevacizumab plus cisplatin versus cisplatin alone for malignant pleural effusion in lung cancer patients: a meta-analysis of randomized controlled trials.
Han X, Qin S, Liu S, Li Z.
World J Surg Oncol. 2025 Jul 14;23(1):278. doi: 10.1186/s12957-025-03887-y.